Clinical Trials Logo

Filter by:
NCT ID: NCT03741075 Recruiting - Clinical trials for Cesarean Section Complications

Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Placenta previa (PP) is an obstetric condition that is closely linked with massive obstetric hemorrhage with a varied incidence about once in every 200 live births. It is considered one of the causes of the increased need for blood transfusion and cesarean hysterectomy. PPH due to PP typically starts during cesarean section (CS) in the placental bed, at the lower uterine segment mostly after placental separation. Proceeding for cesarean hysterectomy can be the only effective line of management in spite of the associated high morbidity rate. Various conservative measures have been developed to avoid hysterectomy and preserve fertility in patients with PP. Bilateral Uterine artery ligation (BUAL) is one of the reported surgical procedures carried out in these cases as it is easy and quick. It can be used alone or with adjunctive measures with a fair success rate. The aim is to reduce the blood supply to the uterus and to prevent postpartum hemorrhage. Tranexamic acid is a lysine analog which acts as an antifibrinolytic via competitive inhibition of the binding of plasmin and plasminogen to fibrin. The rationale for its use in the reduction of blood loss depending on the implication of the coagulation and fibrinolysis processes implicated in the control of PPH. However, concerns about possible thromboembolic events with parenteral administration of TA have stimulated increasing interest in its topical use.

NCT ID: NCT03738059 Recruiting - Skull Pin Insertion Clinical Trials

The Lowest Effective Dose of Dexmedetomidine in Attenuating the Hemodynamic Responses During Skull Pin Insertion in Patients Undergoing Elective Craniotomy

Start date: November 15, 2018
Phase: Early Phase 1
Study type: Interventional

Skull pins are used to immobilize the head during craniotomy. Fixation of skull pins causes acute hemodynamic changes which may affect cerebral autoregulation and hence cerebral blood flow. Therefore, maintenance of stable hemodynamic parameters during skull pin placement under general anesthesia is crucial to ensure adequate cerebral perfusion and prevention of acute rise of intracranial pressure

NCT ID: NCT03737942 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Effect of Type II Diabetes Mellitus With Neuropathy on the Clinical Use of Rocuronium

Start date: November 15, 2018
Phase:
Study type: Observational

International Diabetes Federation estimates that there are now 415 million adults aged 20-79 with diabetes mellitus worldwide. By 2040 this will rise to 640 million. Although diabetes mellitus is highly prevalent in our environment and one of the most important challenges of modern medicine, only a handful of studies have examined the neuromuscular function in diabetic patients. The shortage of publications in this area is still more surprising if we consider that the neuromuscular blockers are one of the pillars in the administration of general anesthesia. Neuromuscular blockers during surgery are used in tracheal intubation and to improve surgical conditions.

NCT ID: NCT03733171 Recruiting - Bleeding Ulcer Clinical Trials

Platelet Rich Plasma in Bleeding Peptic Ulcer

PRP
Start date: September 20, 2018
Phase: N/A
Study type: Interventional

The most common cause of acute upper gastrointestinal bleeding (UGIB) is non-variceal, where peptic ulcer bleeding (PUB) remains the single most common cause, accounting for 25% to 67% of the causes of non-variceal upper gastrointestinal bleeding (NVUGIB). Despite major advances in diagnostic and therapeutic tools, PUB remains a significant problem and an important cause of morbidity and mortality. Given the imperative therapeutic role of endoscopic management in achieving hemostasis in NVUGIB, new modalities to improve the current treatment strategies continue to be developed. Platelet-rich plasma (PRP) is a widely used throughout many fields of medicine for improving tissue regeneration. PRP contains a higher concentration of platelets than whole blood, and represents a pool of many growth-factors.

NCT ID: NCT03732937 Recruiting - Clinical trials for Gestational Age and Weight Conditions

Estimation of Gestational Age by TCD

Start date: November 16, 2018
Phase:
Study type: Observational [Patient Registry]

- Different parameters are used to estimate gestational age AC, HC , BPD and FL

NCT ID: NCT03732040 Recruiting - Dental Caries Clinical Trials

Miswak Versus Standard Measures to Prevent the Incidence of Caries Young Egyptian Adults: A Randomized Controlled Clinical Trial

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Objectives: Aim of the study The objective is to conduct an RCT to evaluate the effectiveness of miswak in comparison with standard caries preventive measures for the prevention of new carious lesions in high caries risk patients. -Research hypothesis (alternative hypothesis): This study will be designed to test the alternative hypothesis that using miswak in addition to standard preventive measures will show significant difference over using standard preventive measures alone in preventing incidence of new carious lesions in high caries risk patients.

NCT ID: NCT03731949 Recruiting - Placenta Diseases Clinical Trials

Placental Volume Analysis During Pregnanay

Start date: November 16, 2018
Phase:
Study type: Observational [Patient Registry]

Placenta grows with advancing gestational age amonitoring of placental growth is important in pregnancy evaluation

NCT ID: NCT03731871 Recruiting - Pregnancy Related Clinical Trials

Parameters of Lung Maturity During Late Pregnancy

Start date: November 12, 2018
Phase:
Study type: Observational

- Lung maturity is one of the most important factors in perinatal medicine

NCT ID: NCT03731858 Recruiting - Infertility Clinical Trials

HbA1c in Intracytoplasmic Sperm Injection

Start date: November 10, 2018
Phase:
Study type: Observational

ICSI has increased nowadays for treating cases of longstanding infertility . HbA1c has an important value in evaluating glucose level in blood

NCT ID: NCT03726177 Recruiting - Preeclampsia Clinical Trials

Aspirin for Prevention of Preeclampsia

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Prophylaxis with low-dose aspirin has been recommended to prevent preeclampsia, the rationale being that hypertension and abnormalities of coagulation in this disease are caused in part by an imbalance between vasodilating and vasoconstricting prostaglandins. Low-dose aspirin therapy inhibits thromboxane production more than prostacyclin production and therefore should protect against vasoconstriction and pathologic blood coagulation in the placenta. Initially, several single-center trials, mostly among women at increased risk for preeclampsia, demonstrated a substantial reduction in the risk of proteinuric hypertension as well as reductions in the incidences of preterm birth, infants small for gestational age, and perinatal death,